Similar increases in CD8+ T cell infiltration in 4T1 or CT26 tumor tissues were observed after OAd-Siglec10-Fc or OAd-TIGIT-Fc treatments (Supplementary Fig. 11). This evidence concerns the gene SIGLEC10 and neoplasm.